journal article·2025-07-09

Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo

Arnab Kumar Sahoo, Antara Mondal, Faisal Jamal, Arpita Das, Khushboo Chaudhary, Aakriti Jha, Tarandeep Singh Bansal, Pritam Mandal, Ashis Kumar Dhara, Yang Yang, Santiswarup Singha

Nano Letters· Volume 25· Issue 27
Publisher page

Abstract

Expanding tumor antigen-specific T-cells in vivo remains a major challenge in developing effective cancer immunotherapeutics. Artificial antigen-presenting cells (aAPCs) have the potential to overcome this challenge, but formulating aAPCs without correlating the in vivo dynamics of T-cell expansion often leads to suboptimal T-cell responses. Here, we have defined the critical effect of the peptide-major histocompatibility complex (p-MHC) valency displayed along with co-stimulatory molecules on iron-oxide nanoparticle-based aAPCs in vivo and demonstrated that the functionality of these aAPCs is governed by the p-MHC valency. Nanoscale aAPCs engage cognate CD8+ T-cells directly to induce the formation of T-cell receptor (TCR) microclusters, leading to nuclear translocation of nuclear factor of activated T-cells (NFAT) in a p-MHC valency-dependent manner. Nanoscale aAPCs, presenting p-MHCs above the threshold valencies, promoted the expansion and tumor infiltration of adoptively transferred and endogenous tumor-specific CD8+ T-cells in tumor situations. The treatment effectively inhibited tumor growth, highlighting the importance of defining the threshold valency of p-MHC in developing aAPCs for effective immunotherapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · T-cell and B-cell Immunology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nano-Biotechnology Laboratory

National Institute of Immunology

Department of Electrical Engineering, National Institute of Technology-Durgapur, Mahatma Gandhi Avenue, Durgapur, West Bengal 713209, India

TANLUN Medical Research and Innovation Inc., #6, XIERQIZHONGLU, Haidian District, Beijing 80086, China

Funding

Indian Council of Medical Research · Science and Engineering Research Board · Department of Biotechnology, Ministry of Science and Technology, India · National Institute of Immunology

References (36)

Show source-provided references
1. 10.1038/s41467-021-25282-310.1038/s41467-021-25282-3 ↗
2. 10.1073/pnas.24260009910.1073/pnas.242600099 ↗
3. 10.1038/s41422-022-00627-910.1038/s41422-022-00627-9 ↗
4. 10.1007/s10517-022-05451-010.1007/s10517-022-05451-0 ↗
5. 10.1021/acsnano.4c0055010.1021/acsnano.4c00550 ↗
6. 10.1038/nature2550110.1038/nature25501 ↗
7. 10.1038/s41467-017-01062-w10.1038/s41467-017-01062-w ↗
8. 10.1016/0022-1759(90)90210-M10.1016/0022-1759(90)90210-M ↗
9. 10.1021/acsnano.2c0621110.1021/acsnano.2c06211 ↗
10. 10.1038/nm86910.1038/nm869 ↗
11. 10.1038/s41596-019-0249-010.1038/s41596-019-0249-0 ↗
12. 10.1021/acsnano.5b0282910.1021/acsnano.5b02829 ↗
13. 10.3324/haematol.1252110.3324/haematol.12521 ↗
14. 10.1021/acssynbio.8b0011910.1021/acssynbio.8b00119 ↗
15. 10.1021/nl080332i10.1021/nl080332i ↗
16. 10.1186/1479-5876-8-10410.1186/1479-5876-8-104 ↗
17. 10.3389/fimmu.2022.100919810.3389/fimmu.2022.1009198 ↗
18. 10.7554/eLife.6561510.7554/eLife.65615 ↗
19. 10.1021/acsnano.2c1188410.1021/acsnano.2c11884 ↗
20. 10.1021/acs.nanolett.7b0373410.1021/acs.nanolett.7b03734 ↗
21. 10.1021/nn405520d10.1021/nn405520d ↗
22. 10.1158/2326-6066.CIR-18-088110.1158/2326-6066.CIR-18-0881 ↗
23. 10.1038/mt.2008.1110.1038/mt.2008.11 ↗
24. 10.1038/nnano.2014.15410.1038/nnano.2014.154 ↗
25. 10.1136/jitc-2023-00684710.1136/jitc-2023-006847 ↗
26. 10.1038/nbt.404710.1038/nbt.4047 ↗
27. 10.1038/nnano.2017.5610.1038/nnano.2017.56 ↗
28. 10.1073/pnas.160743611310.1073/pnas.1607436113 ↗
29. 10.1016/j.immuni.2006.04.01010.1016/j.immuni.2006.04.010 ↗
30. 10.1038/s41598-019-55286-510.1038/s41598-019-55286-5 ↗
31. 10.1038/s41467-019-09893-510.1038/s41467-019-09893-5 ↗
32. 10.1093/intimm/dxq44310.1093/intimm/dxq443 ↗
33. 10.1016/S1074-7613(00)80490-210.1016/S1074-7613(00)80490-2 ↗
34. 10.1038/nature0339110.1038/nature03391 ↗
35. 10.4049/jimmunol.178.5.275510.4049/jimmunol.178.5.2755 ↗
36. 10.1016/j.jconrel.2021.08.04310.1016/j.jconrel.2021.08.043 ↗